Figure 3.
Figure 3. Time to progression and duration of response by t(11;14) status. Presented are the time to progression (A) and duration of response (B) data for patients with t(11;14) MM shown in red, and non-t(11;14) MM [includes patients identified as not having t(11;14) or undetermined cytogenetics] shown in blue. The 2 clinical responses in the non-t(11;14) group were reported in 1 patient with translocation of chromosome 14 with an unidentified partner and in a second patient with missing cytogenetics data. Duration of response for these 2 patients in the non-t(11;14) group was 9.5 and 7.2 months, with both still receiving treatment. NE, not evaluable.

Time to progression and duration of response by t(11;14) status. Presented are the time to progression (A) and duration of response (B) data for patients with t(11;14) MM shown in red, and non-t(11;14) MM [includes patients identified as not having t(11;14) or undetermined cytogenetics] shown in blue. The 2 clinical responses in the non-t(11;14) group were reported in 1 patient with translocation of chromosome 14 with an unidentified partner and in a second patient with missing cytogenetics data. Duration of response for these 2 patients in the non-t(11;14) group was 9.5 and 7.2 months, with both still receiving treatment. NE, not evaluable.

Close Modal

or Create an Account

Close Modal
Close Modal